These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 19773418)
1. Rapamycin enhances lifespan: at last, an advantage for transplant recipients? Geissler EK Nephrol Dial Transplant; 2009 Dec; 24(12):3623-5. PubMed ID: 19773418 [No Abstract] [Full Text] [Related]
2. Rapamycin: immunosuppression, hyporesponsiveness, and side effects in a porcine renal allograft model. Almond PS; Moss A; Nakhleh RE; Melin M; Chen S; Salazar A; Shirabe K; Matas AJ Transplantation; 1993 Aug; 56(2):275-81. PubMed ID: 8356580 [TBL] [Abstract][Full Text] [Related]
3. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys. Bîrsan T; Hausen B; Higgins JP; Hubble RW; Klupp J; Stalder M; Celniker A; Friedrich S; O'Hara RM; Morris RE Transplantation; 2003 Jun; 75(12):2106-13. PubMed ID: 12829920 [TBL] [Abstract][Full Text] [Related]
4. Combined rapamycin and cyclosporine immunosuppression in a porcine renal transplant model. Granger DK; Cromwell JW; Canafax DM; Matas AJ Transplant Proc; 1996 Apr; 28(2):984. PubMed ID: 8623488 [No Abstract] [Full Text] [Related]
5. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH. Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251 [TBL] [Abstract][Full Text] [Related]
6. Rapamycin in a porcine renal transplant model. Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452 [No Abstract] [Full Text] [Related]
7. Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients. Andrés V; Castro C; Campistol JM Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii14-7. PubMed ID: 16815851 [TBL] [Abstract][Full Text] [Related]
8. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
9. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239 [TBL] [Abstract][Full Text] [Related]
10. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat. Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551 [TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Segundo DS; Ruiz JC; Izquierdo M; Fernández-Fresnedo G; Gómez-Alamillo C; Merino R; Benito MJ; Cacho E; Rodrigo E; Palomar R; López-Hoyos M; Arias M Transplantation; 2006 Aug; 82(4):550-7. PubMed ID: 16926600 [TBL] [Abstract][Full Text] [Related]
13. Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation. Stephany BR; Augustine JJ; Krishnamurthi V; Goldfarb DA; Flechner SM; Braun WE; Hricik DE; Dennis VW; Poggio ED Transplantation; 2006 Aug; 82(3):368-74. PubMed ID: 16906035 [TBL] [Abstract][Full Text] [Related]
14. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy. Granger DK; Cromwell JW; Chen SC; Goswitz JJ; Morrow DT; Beierle FA; Sehgal SN; Canafax DM; Matas AJ Transplantation; 1995 Jan; 59(2):183-6. PubMed ID: 7839438 [TBL] [Abstract][Full Text] [Related]
15. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin. Robertson A; Plenter R; Francis DM; Clunie GJ Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279 [No Abstract] [Full Text] [Related]
16. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology. Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433 [TBL] [Abstract][Full Text] [Related]
17. Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog. Ferraresso M; Knight R; Tu Y; Stepkowski SM; Kahan BD Transplant Proc; 1994 Oct; 26(5):3028. PubMed ID: 7940953 [No Abstract] [Full Text] [Related]
18. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116 [TBL] [Abstract][Full Text] [Related]
19. Impact of sirolimus on early graft function after deceased-donor kidney transplantation. McTaggart RA; Tomlanovich SJ; Feng S Transplantation; 2005 Apr; 79(8):991; author reply 991-2. PubMed ID: 15849562 [No Abstract] [Full Text] [Related]
20. Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation. Liu Y; Chen Y; Liu FQ; Lamb JR; Tam PK Transpl Int; 2008 May; 21(5):483-94. PubMed ID: 18266776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]